Smith & Nephew plc
Open
$30.92
Prev. Close
$30.92
High
$30.92
Low
$30.91
Market Snapshot
$13.33B
2.76
$22.46B
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
emptyResult
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Recently from Cashu
Smith & Nephew plc Under Scrutiny: Cramer Recommends Investors Sell Shares Amid Industry Challenges
Smith & Nephew Faces Critical Evaluations Amidst Industry Insights In the latest analysis by Jim Cramer on "Mad Money," Smith & Nephew plc finds itself under scrutiny as the host recommends that inves…
Smith & Nephew plc Under Caution: Jim Cramer Recommends Sell Amid Market Concerns
Smith & Nephew Faces Critical Evaluation Amid Market Recommendations In the latest episode of "Mad Money," host Jim Cramer critically evaluates Smith & Nephew plc, a prominent player in the medical te…
Smith & Nephew plc: Innovating Through Market Volatility and Economic Uncertainty
Smith & Nephew: Navigating Market Volatility Amid Economic Uncertainty In recent days, the healthcare sector has felt the ripple effects of broader market volatility, particularly as investor sentimen…
Smith & Nephew plc: Navigating Market Volatility with Innovation in Healthcare
Smith & Nephew's Position Amid Market Volatility Smith & Nephew plc, a prominent player in the global medical technology sector, operates in an environment characterized by fluctuating investor sentim…